Table 3 Crude and adjusted hazard ratios with confidence intervals from a Cox model after multiple imputation for all HIV-infected deaths during TB treatment

Sex female

0.98 (0.85–1.14)

1.24 (1.06–1.45)

1.23 (1.06–1.44)

Age

 <25

Reference

Reference

Reference

 25–35

1.25 (0.92–1.68)

1.24 (0.92–1.68)

1.25 (0.92–1.70)

 35–45

1.58 (1.16–2.14)

1.60 (1.17–2.18)

1.62 (1.19–2.21)

 45–60

2.39 (1.73–3.29)

2.50 (1.80–3.46)

2.54 (1.83–3.52)

 >60

4.72 (2.99–7.44)

4.79 (3.00–7.65)

4.80 (3.00–7.66)

Anatomic site of TB

 Pulmonary

Reference

Reference

 Extra-pulmonary

1.16 (0.98–1.38)

1.14 (0.93–1.41)

 Both

1.44 (1.12–1.85)

1.29 (1.00–1.68)

Prior TB

1.12 (0.95–1.32)

1.16 (0.98–1.37)

TB smear result

 Smear negative

Reference

Reference

 Smear positive

0.98 (0.83–1.16)

1.07 (0.89–1.28)

 No smear performed

1.16 (0.93–1.45)

1.08 (0.85–1.36)

CD4 count

 <50

Reference

Reference

Reference

 50–100

0.79 (0.61–1.02)

0.79 (0.60–1.02)

0.78 (0.60–1.01)

 100–200

0.55 (0.41–0.75)

0.54 (0.40–0.71)

0.53 (0.40–0.71)

 200–350

0.47 (0.37–0.61)

0.43 (0.34–0.56)

0.43 (0.33–0.55)

 350+

0.28 (0.18–0.43)

0.24 (0.16–0.37)

0.24 (0.16–0.37)

TMP-SMX chemoprophylaxis

1.01 (0.69–1.46)

0.88 (0.60–1.29)

ART during TB treatment

0.76 (0.64–0.91)

0.60 (0.50–0.72)

0.61 (0.51–0.73)